Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

Part of paid clinical trials in Alhambra, California.

Sponsor
Translational Oncology Research International
Study ID
NCT00203424
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Erlotinib + Bevacizumab — DRUG
    Erlotinib every day for 24 weeks and Bevacizumab every 3 weeks for a total of 8 doses

Study Details

The purpose of this study is to evaluate the safety and effectiveness of bevacizumab plus erlotinib following radical prostatectomy.

Key Dates

First listed
Sep 20, 2005
Start date
Jan 31, 2006
Status verified
Feb 2016
Primary completion
Feb 28, 2009
Completion
Jun 30, 2010

Study Design

Enrollment
23 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Erlotinib + Bevacizumab
    Participants received Erlotinib every day for 24 weeks and Bevacizumab every 3 weeks for a total of 8 doses

Primary Outcome Measure

To Evaluate the Efficacy of Bevacizumab Plus Erlotinib [ Time Frame: Determined by time to tumor recurrence, as measured by rising prostate specific antigen (PSA) after radical prostatectomy. ]

Locations (16)

FacilityCityStateZIPSite coordinators
Central Hematology Oncology Medical Group, Inc.AlhambraCalifornia91801-
Comprehensive Blood and Cancer CenterBakersfieldCalifornia93309-
Virginia K. Crosson Cancer CenterFullertonCalifornia92835-
Pacific Shores Medical GroupLong BeachCalifornia90813-
UCLA Medical CenterLos AngelesCalifornia90095-
North Valley Hematology/Oncology Medical GroupNorthridgeCalifornia91328-
Ventura County Hematology-Oncology SpecialistsOxnardCalifornia93030-
Wilshire Oncology Medical Group, Inc.PomonaCalifornia91767-
Cancer Care Associates Medical Group, Inc.Redondo BeachCalifornia90277-
Sansum Santa Barbara Medical Foundation ClinicSanta BarbaraCalifornia93105-
Santa Barbara Hematology Oncology Medical Group, Inc.Santa BarbaraCalifornia93105-
Central Coast Medical Oncology CorporationSanta MariaCalifornia93454-
San Diego Cancer CenterVistaCalifornia92081-
Cancer Institute of Florida, P.A.OrlandoFlorida32804-
Comprehensive Cancer Centers of NevadaLas VegasNevada89109-
South Texas Oncology and Hematology, P.A.San AntonioTexas78207-

Find similar trials in Alhambra, CA

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
Central Hematology Oncology Medical Group, Inc.· Alhambra, CAComprehensive Blood and Cancer Center· Bakersfield, CAVirginia K. Crosson Cancer Center· Fullerton, CAPacific Shores Medical Group· Long Beach, CAUCLA Medical Center· Los Angeles, CANorth Valley Hematology/Oncology Medical Group· Northridge, CA

Related Studies